130 related articles for article (PubMed ID: 3880572)
1. Differential glycosylation requirements for the cell surface expression of class I molecules.
Landolfi NF; Rich RR; Cook RG
J Immunol; 1985 Jan; 134(1):423-30. PubMed ID: 3880572
[TBL] [Abstract][Full Text] [Related]
2. The Qa-1 alloantigens. III. Biochemical analysis of the structure and extent of polymorphism of the Qa-1 allelic products.
Landolfi NF; Rich RR; Cook RG
J Immunol; 1985 Aug; 135(2):1264-70. PubMed ID: 3925004
[TBL] [Abstract][Full Text] [Related]
3. Oligosaccharide-dependent and independent Qa-1 determinants.
Jenkins RN; Aldrich CJ; Lopez LA; Rich RR
J Immunol; 1985 May; 134(5):3218-25. PubMed ID: 2580018
[TBL] [Abstract][Full Text] [Related]
4. Qa-1-associated antigens. IV. Evidence for additional Qa-1 polymorphism defined biochemically and by cytotoxic T lymphocyte recognition.
Nell LJ; Cook RG; Rich RR
Transplantation; 1982 Jul; 34(1):54-9. PubMed ID: 6181592
[TBL] [Abstract][Full Text] [Related]
5. The Qa-1 alloantigens. II. Evidence for the expression of two Qa-1 molecules by the Qa-1d genotype and for cross-reactivity between Qa-1 and H-2K.
Cook RG; Jenkins RN; Flaherty L; Rich RR
J Immunol; 1983 Mar; 130(3):1293-9. PubMed ID: 6822734
[TBL] [Abstract][Full Text] [Related]
6. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
Milisauskas VK; Nakamura I
J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of the molecules reactive with Qa-6 antiserum and the monoclonal antibody 20-8-4: evidence for structural similarity with the Qa-2 molecule.
Widacki SM; Flaherty L; Cook RG
J Immunol; 1985 Nov; 135(5):3333-9. PubMed ID: 2413118
[TBL] [Abstract][Full Text] [Related]
8. Influence of asparagine-linked oligosaccharides on tumor cell recognition in the mixed lymphocyte reaction.
Powell LD; Bause E; Legler G; Molyneux RJ; Hart GW
J Immunol; 1985 Jul; 135(1):714-24. PubMed ID: 3158709
[TBL] [Abstract][Full Text] [Related]
9. Characterization of determinants encoded by four Qa-1 genotypes and their recognition by cloned cytotoxic T lymphocytes.
Jenkins RN; Rich RR
J Immunol; 1983 Nov; 131(5):2147-53. PubMed ID: 6195252
[TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of an MHC-linked hematopoietic cell surface antigen, Qa-2.
Soloski MJ; Vitetta ES; Flaherty L; Uhr JW
J Supramol Struct Cell Biochem; 1981; 16(2):167-77. PubMed ID: 7299842
[TBL] [Abstract][Full Text] [Related]
11. Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression.
Zeff RA; Gopas J; Steinhauer E; Rajan TV; Nathenson SG
J Immunol; 1986 Aug; 137(3):897-903. PubMed ID: 3722821
[TBL] [Abstract][Full Text] [Related]
12. Description of a new Qa antigenic specificity, "Qa-m9," whose expression is under complex genetic control.
Sutton VR; Hogarth PM; McKenzie IF
J Immunol; 1983 Sep; 131(3):1363-7. PubMed ID: 6193187
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
Dialynas DP; Quan ZS; Wall KA; Pierres A; Quintáns J; Loken MR; Pierres M; Fitch FW
J Immunol; 1983 Nov; 131(5):2445-51. PubMed ID: 6415170
[TBL] [Abstract][Full Text] [Related]
14. Association of serum beta 2-microglobulin with H-2 class I heavy chains on the surface of mouse cells in culture.
Kubota K
J Immunol; 1984 Dec; 133(6):3203-10. PubMed ID: 6436377
[TBL] [Abstract][Full Text] [Related]
15. Expression of H-2 and viral antigens and resistance to the antitumor lysis of tunicamycin-treated MBL-2 lymphoma cells.
Colombo MP; Pierotti MA; Ballinari D; Parmiani G
Immunobiology; 1983 Aug; 165(2):186-99. PubMed ID: 6605298
[TBL] [Abstract][Full Text] [Related]
16. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b.
DeCloux A; Woods AS; Cotter RJ; Soloski MJ; Forman J
J Immunol; 1997 Mar; 158(5):2183-91. PubMed ID: 9036964
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glycosylation prevents H-2K and D antigen expression on SV40 virus-transformed cells.
Swaminathan S; Gooding LR
Eur J Immunol; 1983 Apr; 13(4):335-40. PubMed ID: 6303796
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation of CD45: carbohydrate processing through Golgi apparatus is required for cell surface expression and protein stability.
Pulido R; Sánchez-Madrid F
Eur J Immunol; 1992 Feb; 22(2):463-8. PubMed ID: 1531639
[TBL] [Abstract][Full Text] [Related]
19. Slower processing, weaker beta 2-M association, and lower surface expression of H-2Ld are influenced by its amino terminus.
Beck JC; Hansen TH; Cullen SE; Lee DR
J Immunol; 1986 Aug; 137(3):916-23. PubMed ID: 3522739
[TBL] [Abstract][Full Text] [Related]
20. The Qa-1 alloantigens. I. Identification and molecular weight characterization of glycoproteins controlled by the Qa-1a and Qa-1b alleles.
Cook RG; Rich RR; Flaherty L
J Immunol; 1981 Nov; 127(5):1894-8. PubMed ID: 6170678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
